SCHEMBL30870626

SCHEMBL30870626

COc1cc(NC(=O)C2CCC(Nc3cccc(F)c3[N+](=O)[O-])CC2)ccc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.45
▸ NLRP3 Q96P20 1/20 0.40
▸ GRM4 Q14833 1/20 0.40
▸ NAMPT P43490 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ ACHE P22303 1/20 0.39
▸ BACE1 P56817 1/20 0.39
▸ MTNR1A P48039 2/20 0.39
▸ MTNR1B P49286 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28502106 1.00 POLB (0.45) POLBNLRP3GRM4NAMPTTP53
SCHEMBL30870533 0.89 POLB (0.44) POLBNLRP3GRM4NAMPTTP53
SCHEMBL29198166 0.89 POLB (0.44) POLBNLRP3GRM4NAMPTTP53
SCHEMBL29198168 0.89 POLB (0.44) POLBNLRP3GRM4NAMPTTP53
SCHEMBL29198258 0.87 POLB (0.43) POLBNLRP3GRM4NAMPTACHE
SCHEMBL30870547 0.85 EGFR (0.43) POLBNLRP3GRM4TP53MTNR1A
SCHEMBL28512461 0.85 MAPT (0.49) POLBACHEBACE1MAPTLMNA
SCHEMBL30870559 0.85 MAPT (0.49) POLBACHEBACE1MAPTLMNA
SCHEMBL29198178 0.85 EGFR (0.43) POLBNLRP3GRM4TP53MTNR1A
SCHEMBL30870543 0.83 POLB (0.40) POLBNLRP3GRM4ACHEBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-B Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-04-26 — — CN disclosed
Send feedback